Get the highlights.

Depression impacts millions of people, and is the leading cause of disability. But only one third get an effective medicine from the first attempt⁽⁵⁾.

And now citochrome takes the next big step in mental health with a pioneering service__Personalized depression treatment recommendations⁽¹⁾.

Insights so accurate.

It's personal.

The citochrome Wellness Test can spot signs of unsuitable depression treatment

If appropriate, citochrome may recommend a more effective antidepressant to discuss with your doctor.^(2,3)

The world's first personalized Wellness Service.

Receive treatment recommendations by just taking an online test. Get ground breaking insights in your personalized report that will lead to meaningful conversations with your healthcare provider.

Wellness Test

Take an online test from the comfort of your home.

Personalized report

Scientifically validated depression treatment recommendations.

Doctor call

Talk to your doctor, get the most effective medicine.

Questions?

citochrome is built with you in mind. Here are a few commonly asked questions.

What is citochrome?

+

citochrome is an online Wellness Service for depression disorder in adults who are currently taking an antidepressant but still have unresolved symptoms.

How could citochrome help?

+

Supported by research and development, citochrome pioneered new technology to personalize the findings from the largest antidepressant studies like STAR*D, PGRN and others. to get to the correct medicine fast and help brealthrough to relief. Learn more

‍

Concerned about privacy? So are we.

+

We're committed to handling personal data in ways that respect your privacy. Please refer to our Privacy policy and Terms of service for more information regarding processing of your data.

AI-assisted prediction of differential response to antidepressant classes using electronic health records.2023; 6: 73.Published online 2023 Apr 26
Combining machine learning algorithms for prediction of antidepressant treatment response. 2021 Jan; 143(1): 36–49.Published online 2020 Nov 27
The American Sequenced Treatment Alternatives to Relieve Depression (STAR*D) database and European counterparts as the German research network on depression (GRND) or Group for Studies of Resistant Depression (GSRD), enabled progress in predicting treatment outcome on the individual patient level.
The R&D department grouped and analyzed the findings of researchers who used data from the Research Patient Data Registry. The RPDR database includes more than 7 million patients with over 3 billion records seen across seven hospitals, including two major teaching hospitals: Massachusetts General Hospital and Brigham and Women’s Hospital.
What are the treatment remission, response and extent of improvement rates after up to four trials of antidepressant therapies in real-world depressed patients? A reanalysis of the STAR*D study's patient-level data with fidelity to the original research protocol

Important information

By using the citochrome.com website you agree to the terms of service and privacy policy located below. To the extent allowed by applicable law, the citochrome service is provided to you "as is" and without any warranty, express or implied. The information in this Report is for informational and educational purposes only. It is not intended for direct diagnostic use or medical decision making without review by a healthcare provider. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional. Limitations: This product assess the most informative predictors of response and remission. Results may change as research advances and permit us to better understand what these predictors mean for health. Numerous factors can affect response to a medicine, including gender, age, and diet. Not a diagnostic product.

citochrome | Phenocopy LLC

Over-The-Counter Biotechnology products

We're committed to handling personal data in ways that respect your privacy. Please refer to our Privacy policy and Terms of service for more information regarding processing of your data.

Warning: The software and technology components may be subject to United States trade secret protection laws and the Defend Trade Secrets Act.

Pioneering wellness.